BLRX
Price
$4.40
Change
-$0.04 (-0.90%)
Updated
Oct 8 closing price
Capitalization
17.95M
PYXS
Price
$2.91
Change
+$0.36 (+14.12%)
Updated
Oct 8 closing price
Capitalization
180.47M
40 days until earnings call
Interact to see
Advertisement

BLRX vs PYXS

Header iconBLRX vs PYXS Comparison
Open Charts BLRX vs PYXSBanner chart's image
BioLineRx
Price$4.40
Change-$0.04 (-0.90%)
Volume$39.48K
Capitalization17.95M
Pyxis Oncology
Price$2.91
Change+$0.36 (+14.12%)
Volume$851.52K
Capitalization180.47M
BLRX vs PYXS Comparison Chart in %
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. PYXS commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a StrongBuy and PYXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (BLRX: $4.40 vs. PYXS: $2.91)
Brand notoriety: BLRX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 85% vs. PYXS: 125%
Market capitalization -- BLRX: $17.95M vs. PYXS: $180.47M
BLRX [@Biotechnology] is valued at $17.95M. PYXS’s [@Biotechnology] market capitalization is $180.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • BLRX’s TA Score: 5 bullish, 3 bearish.
  • PYXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BLRX is a better buy in the short-term than PYXS.

Price Growth

BLRX (@Biotechnology) experienced а +13.70% price change this week, while PYXS (@Biotechnology) price change was +32.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

PYXS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($180M) has a higher market cap than BLRX($18M). PYXS YTD gains are higher at: 86.538 vs. BLRX (-48.598). BLRX has higher annual earnings (EBITDA): 1.97M vs. PYXS (-83.16M). PYXS has more cash in the bank: 88.9M vs. BLRX (28.2M). BLRX has less debt than PYXS: BLRX (12.6M) vs PYXS (19.5M). BLRX has higher revenues than PYXS: BLRX (17.3M) vs PYXS (2.82M).
BLRXPYXSBLRX / PYXS
Capitalization18M180M10%
EBITDA1.97M-83.16M-2%
Gain YTD-48.59886.538-56%
P/E RatioN/AN/A-
Revenue17.3M2.82M613%
Total Cash28.2M88.9M32%
Total Debt12.6M19.5M65%
FUNDAMENTALS RATINGS
BLRX: Fundamental Ratings
BLRX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLRXPYXS
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBJHF2.06N/A
N/A
Ibstock PLC
ZHSHF1.35N/A
N/A
Zhongsheng Group Holdings Ltd
LKSGF0.01N/A
N/A
Luks Group Vietnam Holdings Co., Ltd.
MGDDY17.74-0.12
-0.67%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
SNBH0.04-0.03
-41.61%
Sentient Brands Holdings Inc.

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+14.12%
KURA - PYXS
61%
Loosely correlated
+6.89%
CABA - PYXS
44%
Loosely correlated
+3.88%
BEAM - PYXS
42%
Loosely correlated
+7.44%
ZBIO - PYXS
42%
Loosely correlated
+24.22%
BLRX - PYXS
39%
Loosely correlated
-0.90%
More